Advert - Advanced Accelerator Applications – Case AUTH/3528/6/21

 

 

For promoting an unlicensed medicine (177Lu-PSMA-617) prior to the grant of the marketing authorisation, Advanced Accelerator Applications (a Novartis company) was ruled in breach of the following clauses of the 2019 Code:

 

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 3.1 - Promoting an unlicensed medicine

Clause 9.1 - Failing to maintain high standards